Efficacy/effectiveness Safety Newborn (0-1 years) Children (2-9 years) Adolescents (10-18 years) Mumps Measles Rubella Varicella
Efficacy/effectiveness Newborn (0-1 years) Children (2-9 years) Hepatitis A
Economic aspects All age groups Influenza Rotavirus Meningococcal disease Pneumococcal disease Hepatitis B Varicella
Economic aspects All age groups Germany Mumps Measles Pertussis Varicella
Safety Efficacy/effectiveness All age groups Healthcare workers Hepatitis A Hepatitis B
Varicella
Hepatitis A
Varicella
Download:
Efficacy/effectiveness Safety Administration Newborn (0-1 years) Children (2-9 years) Mumps Measles Rubella Varicella
Safety Newborn (0-1 years) Children (2-9 years) Mumps Measles Rubella Varicella